Medication info

B&CDapagliflozin 10 mg (Dapagliflozin Propanediol Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
B&C Co., Ltd.
Appearance
Yellow, biconvex diamond-shaped film-coated tablets
Packaging
28 tablets/box [7 tablets/PTP (Alu-Alu) x 4]
Approval status
Active

MFDS item code 202300425 · Approved 2023.01.31

Summary

Main use
Improves glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, when administered in combination with metformin, the recommended initial dose of this medicine is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine is not recommended to improve glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Children under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Ingredients

Manufacturer
B&C Co., Ltd.

Efficacy & effects

Improves glycemic control in patients with type 2 diabetes mellitus

  • Type 2 diabetes
  • impaired blood glucose control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used to help control blood glucose levels in patients with type 2 diabetes. It can be administered alone or in combination with dietary and exercise therapies. It is particularly considered for patients whose blood glucose is not adequately controlled and who have cardiovascular disease or cardiovascular risk factors. The cardiovascular effects of the drug should be carefully observed according to expert guidelines. Overall, this medication safely and effectively improves diabetes blood glucose management.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, when administered in combination with metformin, the recommended initial dose of this medicine is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this medicine is not recommended to improve glycemic control. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Children under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Precautions

This medication should not be used in patients who are allergic to the active ingredients or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. In patients with genetic lactose intolerance or lactase deficiency, and glucose-galactose malabsorption disorders, administration may pose risks. This medication is also not used in patients undergoing dialysis treatment. It should be used cautiously in patients with reduced fluid volume or impaired kidney function. This medication can lower blood pressure and affect kidney function, therefore the fluid status and kidney function should be closely monitored before and during administration. In patients with moderate to severe renal impairment, the effectiveness in blood glucose control may be reduced, requiring careful attention. Various adverse reactions may occur, including genital infections, urinary tract infections, hypoglycemia, dehydration, diabetic ketoacidosis among others. Genital infections especially may occur more frequently in women and patients with a history of such infections. Hypoglycemia may occur more frequently when used with medications like insulin or sulfonylureas, necessitating dose adjustments. Dehydration or low blood pressure symptoms may appear due to reduced fluid volume, hence symptoms should be monitored closely. Diabetic ketoacidosis may occur even without high blood glucose levels; therefore, immediate examination and treatment are necessary if symptoms such as vomiting, abdominal pain, or breathing difficulties arise. This medication is not recommended for patients with severely impaired liver function. Elderly patients are at increased risk for decreased kidney function and fluid volume loss, and extra caution is warranted. Administration may cause glucose detection in urine tests affecting blood glucose control tests. To mitigate hypoglycemia risk when used with insulin or sulfonylureas, dose adjustments may be required. When used with certain diuretics, caution is warranted as risks of dehydration and low blood pressure may increase. Pregnant or nursing women should avoid this medication. There is no specific antidote for overdose, but appropriate treatment based on symptoms is advised. This medication does not significantly affect driving or operating machinery, but caution is necessary if hypoglycemia risk exists. Safety and efficacy have not been established in pediatric patients, and it is not used in this population. It should be stored out of reach of children and in the original container.

Side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, initial treatment decrease in renal creatinine clearance, dyslipidemia, initial treatment increase in serum creatinine, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, fatigue, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, uroseptic shock, acute kidney injury, renal dysfunction, chest pain, chest discomfort, edema, facial swelling, facial pain, warmth, flu-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularity, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, nummular eczema, eczema, hyperkeratosis, nail hyperpigmentation, skin lesions, urticaria, cold sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, dry eye, eye pain, retinal disorders, vision loss, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, high intraocular pressure, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, tinnitus, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, loss of consciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, chest pain, fatigue, pain, hunger, vaginal discharge, itching, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. The optimal storage temperature is between 1°C and 30°C at room temperature.

Appearance and packaging

Appearance

Yellow, biconvex diamond-shaped film-coated tablets

Package unit

28 tablets/box [7 tablets/PTP (Alu-Alu) x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.